Mesoblast implants two with adult stem cells
Monday, 06 February, 2006
The first two patients in Melbourne-based Mesoblast's (ASX:MSB) clinical trials have been implanted with adult stem cells.
"The procedure went well and both patients have been discharged from hospital," said principal investigator Dr Suku Thambar, an interventional cardiologist from the Hunter Medical Research Institute, in a statement. "We will closely monitor the patients' progress and look forward to seeing evidence of clinical improvement in a short period of time."
The trial, for the treatment of cardiovascular disease, is one of two currently being conducted in Australia to test the safety of Mesoblast's proprietary adult stem cell technology in humans. The other is for the repair of large bone fractures, and is being done at the Royal Melbourne Hospital.
Mesoblast's shares were up $0.07 to $1.37, more than 5 per cent, at press time.
COVID vaccine candidate protects against multiple variants
By targeting features shared by a range of coronaviruses, the vaccine is designed to offer...
Stevia leaf extract has potential as an anticancer treatment
When fermented with bacteria isolated from banana leaves, stevia extract kills off pancreatic...
Even non-antibiotics can disrupt the microbiome
Many non-antibiotics inhibit useful gut bacteria, giving rise to an imbalance in the microbiome,...
